MiMedx Group Inc.
MDXG | NASDAQ
$4.89
+$0.08 (+1.66%)
Sep 22, 2026, 12:58 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 418.63M | 348.88M | 321.48M | 267.84M | 242.02M | 248.23M |
Cost of Revenue | 73.01M | 60.07M | 54.63M | 48.32M | 39.63M | 39.33M |
Gross Profit | 345.62M | 288.81M | 266.84M | 219.53M | 202.39M | 208.9M |
Operating Income | 63.89M | 58.87M | 37.12M | -14.73M | -7.05M | -45.4M |
Interest Income | 4.72M | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 66.26M | 57.29M | 30.63M | -19.75M | -12.05M | -61.54M |
Net Income | 48.58M | 42.42M | 67.44M | -30.2M | -12.3M | -49.28M |
Selling & General & Admin | 266.19M | 216.39M | 216.3M | 220.85M | 194.85M | 240.49M |
Research & Development | 15.1M | 12.34M | 12.67M | 12.7M | 9.93M | 11.72M |
Other Expenses | n/a | 1.21M | 762K | 701K | 4.66M | 2.1M |
Operating Expenses | 281.29M | 229.94M | 229.73M | 234.25M | 209.44M | 254.3M |
Interest Expense | 1.78M | 1.01M | 6.46M | 5.02M | 4.98M | 7.94M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 354.74M | 290.01M | 284.36M | 282.57M | 249.07M | 293.63M |
Income Tax Expense | 17.68M | 15.3M | -36.81M | 206K | 247K | -12.26M |
Shares Outstanding (Basic) | 147.79M | 146.98M | 116.5M | 112.91M | 110.35M | 108.26M |
Shares Outstanding (Diluted) | 149.72M | 149.05M | 145.96M | 112.91M | 110.35M | 108.26M |
EPS (Basic) | 0.33 | 0.29 | 0.48 | -0.27 | -0.09 | -0.46 |
EPS (Diluted) | 0.32 | 0.28 | 0.38 | -0.27 | -0.09 | -0.46 |
EBITDA | 82.93M | 65.35M | 40.52M | -10.69M | -1.89M | -37.52M |
EBIT | 68.05M | 59.31M | 37.09M | -14.73M | -7.07M | -44.37M |
Depreciation & Amortization | 14.88M | 6.04M | 3.43M | 4.05M | 5.18M | 6.86M |
Add to Watchlist
Select watchlists to add or remove MDXG